{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:07:53Z","timestamp":1790327273498,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12035-023-03810-0","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T08:02:32Z","timestamp":1701676952000},"page":"4021-4037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Microglia as a Game Changer in Epilepsy Comorbid Depression"],"prefix":"10.1007","volume":"61","author":[{"given":"Wenrong","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2019an","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3509-0790","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"3810_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yebeh.2015.01.005","volume":"45","author":"R Andrade-Machado","year":"2015","unstructured":"Andrade-Machado R et al (2015) Suicidal risk, affective dysphoric disorders, and quality-of-life perception in patients with focal refractory epilepsy. Epilepsy Behav 45:254\u2013260","journal-title":"Epilepsy Behav"},{"key":"3810_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1176\/jnp.17.1.20","volume":"17","author":"P Christian","year":"2005","unstructured":"Christian P, Christine N (2005) Mood disorders and their treatment in patients with epilepsy. he. J Neuropsychiatry Clin Neurosci 17:20\u201328","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"6","key":"3810_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1134\/S0006297921060031","volume":"86","author":"NV Gulyaeva","year":"2021","unstructured":"Gulyaeva NV (2021) Stress-associated molecular and cellular hippocampal mechanisms common for epilepsy and comorbid depressive disorders. Biochemistry (Mosc) 86(6):641\u2013656","journal-title":"Biochemistry (Mosc)"},{"key":"3810_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000054795","volume":"20","author":"V Rafnsson","year":"2001","unstructured":"Rafnsson V, \u00d3lafsson E, Hauser WA (2001) Gunnar Gudmundsson, Cause-specific mortality in adults with unprovoked seizures. Neuroepidemiology 20:232\u2013236","journal-title":"Neuroepidemiology"},{"key":"3810_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yebeh.2014.08.023","volume":"39","author":"KM Fiest","year":"2014","unstructured":"Fiest KM et al (2014) Patterns and frequency of the treatment of depression in persons with epilepsy. Epilepsy Behav 39:59\u201364","journal-title":"Epilepsy Behav"},{"issue":"Pt 10","key":"3810_CR6","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/brain\/awn194","volume":"131","author":"A Lothe","year":"2008","unstructured":"Lothe A et al (2008) Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131(Pt 10):2765\u20132782","journal-title":"Brain"},{"issue":"Suppl 1","key":"3810_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/epi.12100","volume":"54","author":"AM Kanner","year":"2013","unstructured":"Kanner AM (2013) The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia 54(Suppl 1):3\u201312","journal-title":"Epilepsia"},{"issue":"3","key":"3810_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nn.3934","volume":"18","author":"BP Grone","year":"2015","unstructured":"Grone BP, Baraban SC (2015) Animal models in epilepsy research: legacies and new directions. Nat Neurosci 18(3):339\u2013343","journal-title":"Nat Neurosci"},{"issue":"1","key":"3810_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/epi.17433","volume":"64","author":"W Loscher","year":"2023","unstructured":"Loscher W, Stafstrom CE (2023) Epilepsy and its neurobehavioral comorbidities: insights gained from animal models. Epilepsia 64(1):54\u201391","journal-title":"Epilepsia"},{"key":"3810_CR10","doi-asserted-by":"crossref","unstructured":"Vezzani A (2014) Epilepsy and inflammation in the brain: overview and pathophysiology. 14:3\u20137","DOI":"10.5698\/1535-7511-14.s2.3"},{"key":"3810_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/7854_2020_192","volume":"55","author":"J Maguire","year":"2022","unstructured":"Maguire J (2022) Mechanisms of psychiatric comorbidities in epilepsy. Curr Top Behav Neurosci 55:107\u2013144","journal-title":"Curr Top Behav Neurosci"},{"key":"3810_CR12","unstructured":"Wells GA et al. (2021) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"1","key":"3810_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.yebeh.2011.11.001","volume":"23","author":"D Crail-Melendez","year":"2012","unstructured":"Crail-Melendez D et al (2012) Cognitive-behavioral therapy for depression in patients with temporal lobe epilepsy: a pilot study. Epilepsy Behav 23(1):52\u201356","journal-title":"Epilepsy Behav"},{"issue":"1","key":"3810_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.yebeh.2010.10.028","volume":"20","author":"S Macrodimitris","year":"2011","unstructured":"Macrodimitris S et al (2011) Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety. Epilepsy Behav 20(1):83\u201388","journal-title":"Epilepsy Behav"},{"key":"3810_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.03.023","volume":"58","author":"ACS de Barros","year":"2018","unstructured":"de Barros ACS et al (2018) Effects of a psychotherapeutic group intervention in patients with refractory mesial temporal lobe epilepsy and comorbid psychogenic nonepileptic seizures: a nonrandomized controlled study. Seizure 58:22\u201328","journal-title":"Seizure"},{"issue":"6","key":"3810_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.yebeh.2003.08.009","volume":"4","author":"KU Kuhn","year":"2003","unstructured":"Kuhn KU et al (2003) Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4(6):674\u2013679","journal-title":"Epilepsy Behav"},{"key":"3810_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00002826-200405000-00009","volume":"27","author":"LM Specchio","year":"2004","unstructured":"Specchio LM et al (2004) Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 27:133\u2013136","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"3810_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ana.25561","volume":"86","author":"FG Gilliam","year":"2019","unstructured":"Gilliam FG et al (2019) A trial of sertraline or cognitive behavior therapy for depression in epilepsy. Ann Neurol 86(4):552\u2013560","journal-title":"Ann Neurol"},{"key":"3810_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.yebeh.2015.07.033","volume":"51","author":"JM Orjuela-Rojas","year":"2015","unstructured":"Orjuela-Rojas JM et al (2015) Treatment of depression in patients with temporal lobe epilepsy: a pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors. Epilepsy Behav 51:176\u2013181","journal-title":"Epilepsy Behav"},{"issue":"3","key":"3810_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.yebeh.2007.01.004","volume":"10","author":"MS Thome-Souza","year":"2007","unstructured":"Thome-Souza MS, Kuczynski E, Valente KD (2007) Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 10(3):417\u2013425","journal-title":"Epilepsy Behav"},{"issue":"2","key":"3810_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/16506073.2014.892530","volume":"43","author":"M Gandy","year":"2014","unstructured":"Gandy M et al (2014) Cognitive behaviour therapy to improve mood in people with epilepsy: a randomised controlled trial. Cogn Behav Ther 43(2):153\u2013166","journal-title":"Cogn Behav Ther"},{"issue":"1","key":"3810_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuron.2012.12.023","volume":"77","author":"H Kettenmann","year":"2013","unstructured":"Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: new roles for the synaptic stripper. Neuron 77(1):10\u201318","journal-title":"Neuron"},{"issue":"5","key":"3810_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87(5):779\u2013789","journal-title":"J Leukoc Biol"},{"issue":"2","key":"3810_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","volume":"179","author":"M Prinz","year":"2019","unstructured":"Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179(2):292\u2013311","journal-title":"Cell"},{"key":"3810_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fncel.2014.00362","volume":"8","author":"AC da Fonseca","year":"2014","unstructured":"da Fonseca AC et al (2014) The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 8:362","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"3810_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12974-019-1398-3","volume":"16","author":"Q Liu","year":"2019","unstructured":"Liu Q et al (2019) Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca(2+)-dependent PKC\/p38MAPK\/NF-kappaB pathway. J Neuroinflammation 16(1):10","journal-title":"J Neuroinflammation"},{"issue":"2","key":"3810_CR27","doi-asserted-by":"publisher","first-page":"e100440","DOI":"10.1136\/gpsych-2020-100440","volume":"34","author":"X Guo","year":"2021","unstructured":"Guo X et al (2021) PAID study design on the role of PKC activation in immune\/inflammation-related depression: a randomised placebo-controlled trial protocol. Gen Psychiatr 34(2):e100440","journal-title":"Gen Psychiatr"},{"key":"3810_CR28","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/j.neuropharm.2020.108336","volume":"181","author":"X Guo","year":"2020","unstructured":"Guo X et al (2020) Common cellular and molecular mechanisms and interactions between microglial activation and aberrant neuroplasticity in depression. Neuropharmacology 181:108336","journal-title":"Neuropharmacology"},{"key":"3810_CR29","doi-asserted-by":"crossref","unstructured":"Wu H et al (2021) Mer regulates microglial\/macrophage M1\/M2 polarization and alleviates neuroinflammation following traumatic brain injury.\u00a0J Neuroinflammation 18(2)","DOI":"10.1186\/s12974-020-02041-7"},{"key":"3810_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2020.06.028","volume":"89","author":"W Wu","year":"2020","unstructured":"Wu W et al (2020) Microglial depletion aggravates the severity of acute and chronic seizures in mice. Brain Behav Immun 89:245\u2013255","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3810_CR31","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K et al (2019) Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 10(1):5816","journal-title":"Nat Commun"},{"issue":"6","key":"3810_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/epi.12960","volume":"56","author":"MJ Benson","year":"2015","unstructured":"Benson MJ, Manzanero S, Borges K (2015) Complex alterations in microglial M1\/M2 markers during the development of epilepsy in two mouse models. Epilepsia 56(6):895\u2013905","journal-title":"Epilepsia"},{"key":"3810_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache D, Pariante CM, Mondelli V (2019) Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun 81:24\u201340","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3810_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22\u201334","journal-title":"Nat Rev Immunol"},{"key":"3810_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","volume":"42","author":"SG Torres-Platas","year":"2014","unstructured":"Torres-Platas SG et al (2014) Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 42:50\u201359","journal-title":"Brain Behav Immun"},{"key":"3810_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fncel.2018.00306","volume":"12","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang J, You Z (2018) Switching of the microglial activation phenotype is a possible treatment for depression disorder. Front Cell Neurosci 12:306","journal-title":"Front Cell Neurosci"},{"key":"3810_CR37","doi-asserted-by":"publisher","first-page":"112296","DOI":"10.1016\/j.bbr.2019.112296","volume":"378","author":"CM Duan","year":"2020","unstructured":"Duan CM et al (2020) SRT2104 attenuates chronic unpredictable mild stress-induced depressive-like behaviors and imbalance between microglial M1 and M2 phenotypes in the mice. Behav Brain Res 378:112296","journal-title":"Behav Brain Res"},{"issue":"1","key":"3810_CR38","doi-asserted-by":"publisher","first-page":"e12758","DOI":"10.1111\/nan.12758","volume":"48","author":"A Altmann","year":"2022","unstructured":"Altmann A et al (2022) A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies. Neuropathol Appl Neurobiol 48(1):e12758","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7416","key":"3810_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz MJ et al (2012) An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489(7416):391\u2013399","journal-title":"Nature"},{"issue":"6","key":"3810_CR40","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/brain\/awz074","volume":"142","author":"S Guelfi","year":"2019","unstructured":"Guelfi S et al (2019) Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy. Brain 142(6):1616\u20131630","journal-title":"Brain"},{"issue":"12","key":"3810_CR41","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1093\/brain\/awy276","volume":"141","author":"M Morin-Brureau","year":"2018","unstructured":"Morin-Brureau M et al (2018) Microglial phenotypes in the human epileptic temporal lobe. Brain 141(12):3343\u20133360","journal-title":"Brain"},{"issue":"s1","key":"3810_CR42","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.3233\/JAD-230059","volume":"94","author":"Y Liew","year":"2023","unstructured":"Liew Y et al (2023) Neuroinflammation: a common pathway in Alzheimer\u2019s disease and epilepsy. J Alzheimers Dis 94(s1):S253\u2013S265","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3810_CR43","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12974-021-02309-6","volume":"18","author":"SC Woodburn","year":"2021","unstructured":"Woodburn SC, Bollinger JL, Wohleb ES (2021) The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation 18(1):258","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3810_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat R et al (2021) Neuroinflammation and depression: a review. Eur J Neurosci 53(1):151\u2013171","journal-title":"Eur J Neurosci"},{"key":"3810_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbi.2019.06.012","volume":"81","author":"LL Liu","year":"2019","unstructured":"Liu LL et al (2019) Sex differences in depressive-like behaviour may relate to imbalance of microglia activation in the hippocampus. Brain Behav Immun 81:188\u2013197","journal-title":"Brain Behav Immun"},{"issue":"6","key":"3810_CR46","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Munoz-Planillo","year":"2013","unstructured":"Munoz-Planillo R et al (2013) K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6):1142\u20131153","journal-title":"Immunity"},{"issue":"11","key":"3810_CR47","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1021\/acs.jmedchem.5b00671","volume":"59","author":"D Vivier","year":"2016","unstructured":"Vivier D et al (2016) Perspectives on the two-pore domain potassium channel TREK-1 (TWIK-Related K(+) channel 1). A novel therapeutic target? J Med Chem 59(11):5149\u20135157","journal-title":"J Med Chem"},{"issue":"2","key":"3810_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/cns.13450","volume":"27","author":"F Wu","year":"2021","unstructured":"Wu F et al (2021) Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice. CNS Neurosci Ther 27(2):220\u2013232","journal-title":"CNS Neurosci Ther"},{"key":"3810_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fphar.2019.00379","volume":"10","author":"A Djillani","year":"2019","unstructured":"Djillani A et al (2019) Role of TREK-1 in health and disease, focus on the central nervous system. Front Pharmacol 10:379","journal-title":"Front Pharmacol"},{"issue":"9","key":"3810_CR50","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/nn1749","volume":"9","author":"C Heurteaux","year":"2006","unstructured":"Heurteaux C et al (2006) Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9(9):1134\u20131141","journal-title":"Nat Neurosci"},{"issue":"1","key":"3810_CR51","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41467-017-00499-3","volume":"8","author":"Q Luo","year":"2017","unstructured":"Luo Q et al (2017) An allosteric ligand-binding site in the extracellular cap of K2P channels. Nat Commun 8(1):378","journal-title":"Nat Commun"},{"issue":"7","key":"3810_CR52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"MA Rogawski","year":"2004","unstructured":"Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5(7):553\u2013564","journal-title":"Nat Rev Neurosci"},{"key":"3810_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0306-4522(01)00030-6","volume":"103","author":"GJ Hervieu","year":"2001","unstructured":"Hervieu GJ et al (2001) Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 103:899\u2013919","journal-title":"Neuroscience"},{"issue":"13","key":"3810_CR54","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/sj.emboj.7600234","volume":"23","author":"C Heurteaux","year":"2004","unstructured":"Heurteaux C et al (2004) TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J 23(13):2684\u20132695","journal-title":"EMBO J"},{"issue":"6","key":"3810_CR55","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.neuron.2012.04.026","volume":"74","author":"G Sandoz","year":"2012","unstructured":"Sandoz G et al (2012) Optical control of endogenous proteins with a photoswitchable conditional subunit reveals a role for TREK1 in GABA(B) signaling. Neuron 74(6):1005\u20131014","journal-title":"Neuron"},{"issue":"Pt A","key":"3810_CR56","doi-asserted-by":"publisher","first-page":"108045","DOI":"10.1016\/j.yebeh.2021.108045","volume":"121","author":"XL Li","year":"2021","unstructured":"Li XL et al (2021) Regulation of TWIK-related K(+) channel 1 in the anterior hippocampus of patients with temporal lobe epilepsy with comorbid depression. Epilepsy Behav 121(Pt A):108045","journal-title":"Epilepsy Behav"},{"issue":"1","key":"3810_CR57","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12974-020-01871-9","volume":"17","author":"HY Zhang","year":"2020","unstructured":"Zhang HY et al (2020) A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment. J Neuroinflammation 17(1):200","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3810_CR58","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/pr.112.006171","volume":"65","author":"F Di Virgilio","year":"2013","unstructured":"Di Virgilio F (2013) The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol Rev 65(3):872\u2013905","journal-title":"Pharmacol Rev"},{"key":"3810_CR59","doi-asserted-by":"crossref","unstructured":"Conte G et al (2021) Circulating P2X7 receptor signaling components as diagnostic biomarkers for temporal lobe epilepsy. Cells 10(9):2444","DOI":"10.3390\/cells10092444"},{"key":"3810_CR60","doi-asserted-by":"publisher","first-page":"101855","DOI":"10.1016\/j.jchemneu.2020.101855","volume":"110","author":"N Jamali-Raeufy","year":"2020","unstructured":"Jamali-Raeufy N et al (2020) Combination therapy with dipeptidyl peptidase-4 and P2X7 purinoceptor inhibitors gives rise to antiepileptic effects in rats. J Chem Neuroanat 110:101855","journal-title":"J Chem Neuroanat"},{"issue":"6","key":"3810_CR61","first-page":"5433","volume":"19","author":"P Song","year":"2019","unstructured":"Song P et al (2019) Increased expression of the P2X7 receptor in temporal lobe epilepsy: animal models and clinical evidence. Mol Med Rep 19(6):5433\u20135439","journal-title":"Mol Med Rep"},{"key":"3810_CR62","doi-asserted-by":"publisher","first-page":"104773","DOI":"10.1016\/j.neuint.2020.104773","volume":"138","author":"S Hong","year":"2020","unstructured":"Hong S et al (2020) The P2X7 receptor in activated microglia promotes depression- and anxiety-like behaviors in lithium -pilocarpine induced epileptic rats. Neurochem Int 138:104773","journal-title":"Neurochem Int"},{"issue":"1","key":"3810_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","volume":"14","author":"N Yue","year":"2017","unstructured":"Yue N et al (2017) Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors. J Neuroinflammation 14(1):102","journal-title":"J Neuroinflammation"},{"key":"3810_CR64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbi.2016.04.012","volume":"56","author":"NT Fiore","year":"2016","unstructured":"Fiore NT, Austin PJ (2016) Are the emergence of affective disturbances in neuropathic pain states contingent on supraspinal neuroinflammation? Brain Behav Immun 56:397\u2013411","journal-title":"Brain Behav Immun"},{"issue":"15","key":"3810_CR65","doi-asserted-by":"publisher","first-page":"13309","DOI":"10.1074\/jbc.M209478200","volume":"278","author":"LK Parvathenani","year":"2003","unstructured":"Parvathenani LK et al (2003) P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer\u2019s disease. J Biol Chem 278(15):13309\u201313317","journal-title":"J Biol Chem"},{"key":"3810_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13578-020-00388-1","volume":"10","author":"D Wang","year":"2020","unstructured":"Wang D et al (2020) P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes. Cell Biosci 10:28","journal-title":"Cell Biosci"},{"key":"3810_CR67","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3389\/fneur.2019.01418","volume":"10","author":"C Wu","year":"2019","unstructured":"Wu C et al (2019) The role of NLRP3 and IL-1beta in refractory epilepsy brain injury. Front Neurol 10:1418","journal-title":"Front Neurol"},{"key":"3810_CR68","first-page":"497","volume":"292","author":"S Wang","year":"2000","unstructured":"Wang S et al (2000) Interleukin-1\u03b2 inhibits \u03b3-aminobutyric acid type A (GABAA) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 292:497\u2013504","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"3810_CR69","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12015-019-09888-1","volume":"15","author":"MZ Ratajczak","year":"2019","unstructured":"Ratajczak MZ et al (2019) ATP-Nlrp3 inflammasome-complement cascade axis in sterile brain inflammation in psychiatric patients and its impact on stem cell trafficking. Stem Cell Rev Rep 15(4):497\u2013505","journal-title":"Stem Cell Rev Rep"},{"issue":"10","key":"3810_CR70","doi-asserted-by":"publisher","first-page":"e110185","DOI":"10.1371\/journal.pone.0110185","volume":"9","author":"LC Moncao-Ribeiro","year":"2014","unstructured":"Moncao-Ribeiro LC et al (2014) P2X7 receptor modulates inflammatory and functional pulmonary changes induced by silica. PLoS One 9(10):e110185","journal-title":"PLoS One"},{"issue":"6","key":"3810_CR71","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1164\/rccm.201003-0359OC","volume":"182","author":"N Riteau","year":"2010","unstructured":"Riteau N et al (2010) Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med 182(6):774\u2013783","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3810_CR72","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4103\/joacp.JOACP_562_20","volume":"37","author":"A Rylova","year":"2021","unstructured":"Rylova A et al (2021) Intravenous lidocaine infusion in a case of severe COVID-19 infection. J Anaesthesiol Clin Pharmacol 37(3):481\u2013483","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"3810_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnins.2017.00021","volume":"11","author":"E Beamer","year":"2017","unstructured":"Beamer E, Fischer W, Engel T (2017) The ATP-gated P2X7 receptor as a target for the treatment of drug-resistant epilepsy. Front Neurosci 11:21","journal-title":"Front Neurosci"},{"issue":"8","key":"3810_CR74","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1096\/fj.06-7238com","volume":"21","author":"M Baroni","year":"2007","unstructured":"Baroni M et al (2007) Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J 21(8):1926\u20131933","journal-title":"FASEB J"},{"issue":"7","key":"3810_CR75","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1172\/JCI46129","volume":"121","author":"C Furlan-Freguia","year":"2011","unstructured":"Furlan-Freguia C et al (2011) P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 121(7):2932\u20132944","journal-title":"J Clin Invest"},{"key":"3810_CR76","doi-asserted-by":"publisher","first-page":"786579","DOI":"10.3389\/fphar.2021.786579","volume":"12","author":"N Cheng","year":"2021","unstructured":"Cheng N, Zhang L, Liu L (2021) Understanding the role of purinergic P2X7 receptors in the gastrointestinal system: a systematic review. Front Pharmacol 12:786579","journal-title":"Front Pharmacol"},{"key":"3810_CR77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12974-015-0266-z","volume":"12","author":"L Kandratavicius","year":"2015","unstructured":"Kandratavicius L et al (2015) Mesial temporal lobe epilepsy with psychiatric comorbidities: a place for differential neuroinflammatory interplay. J Neuroinflammation 12:38","journal-title":"J Neuroinflammation"},{"issue":"1-2","key":"3810_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jneuroim.2012.08.004","volume":"254","author":"T Quirico-Santos","year":"2013","unstructured":"Quirico-Santos T et al (2013) Resection of the epileptogenic lesion abolishes seizures and reduces inflammatory cytokines of patients with temporal lobe epilepsy. J Neuroimmunol 254(1-2):125\u2013130","journal-title":"J Neuroimmunol"},{"issue":"1","key":"3810_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biopsych.2015.11.026","volume":"80","author":"M Iwata","year":"2016","unstructured":"Iwata M et al (2016) Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol Psychiatry 80(1):12\u201322","journal-title":"Biol Psychiatry"},{"issue":"1","key":"3810_CR80","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12974-021-02303-y","volume":"18","author":"H Li","year":"2021","unstructured":"Li H et al (2021) Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat. J Neuroinflammation 18(1):254","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3810_CR81","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.nbd.2009.02.018","volume":"34","author":"AM Mazarati","year":"2009","unstructured":"Mazarati AM et al (2009) Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol Dis 34(3):457\u2013461","journal-title":"Neurobiol Dis"},{"key":"3810_CR82","doi-asserted-by":"crossref","unstructured":"Mazarati AM, Pineda E, Shin D, Tio D, Taylor AN, Sankar R (2010) Comorbidity between epilepsy and depression: role of hippocampal interleukin-1\u03b2. Neurobiol Dis:37(2):461\u2013467","DOI":"10.1016\/j.nbd.2009.11.001"},{"key":"3810_CR83","doi-asserted-by":"crossref","unstructured":"Trina Basu JM, Jay A (2021) Salpekar, Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy. Neurosci Lett 16(746):135618","DOI":"10.1016\/j.neulet.2020.135618"},{"issue":"1","key":"3810_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.psyneuen.2011.04.014","volume":"37","author":"EI Flandreau","year":"2012","unstructured":"Flandreau EI et al (2012) Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 37(1):27\u201338","journal-title":"Psychoneuroendocrinology"},{"key":"3810_CR85","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jad.2017.11.094","volume":"228","author":"LA Quagliato","year":"2018","unstructured":"Quagliato LA, Nardi AE (2018) Cytokine alterations in panic disorder: a systematic review. J Affect Disord 228:91\u201396","journal-title":"J Affect Disord"},{"key":"3810_CR86","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.yebeh.2017.10.025","volume":"78","author":"A Hooper","year":"2018","unstructured":"Hooper A, Paracha R, Maguire J (2018) Seizure-induced activation of the HPA axis increases seizure frequency and comorbid depression-like behaviors. Epilepsy Behav 78:124\u2013133","journal-title":"Epilepsy Behav"},{"key":"3810_CR87","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuroscience.2020.05.014","volume":"440","author":"NM Vega-Rivera","year":"2020","unstructured":"Vega-Rivera NM et al (2020) Melatonin reverses the depression-associated behaviour and regulates microglia, fractalkine expression and neurogenesis in adult mice exposed to chronic mild stress. Neuroscience 440:316\u2013336","journal-title":"Neuroscience"},{"issue":"11","key":"3810_CR88","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tins.2007.08.007","volume":"30","author":"K Biber","year":"2007","unstructured":"Biber K et al (2007) Neuronal \u2018On\u2019 and \u2018Off\u2019 signals control microglia. Trends Neurosci 30(11):596\u2013602","journal-title":"Trends Neurosci"},{"issue":"29","key":"3810_CR89","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1523\/JNEUROSCI.4363-08.2009","volume":"13","author":"AJMS Hiroaki Wake","year":"2009","unstructured":"Hiroaki Wake AJMS (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 13(29):3974\u20133980","journal-title":"J Neurosci"},{"key":"3810_CR90","doi-asserted-by":"crossref","unstructured":"Tremblay M\u00c8, Lowery RL, Majewska AK (2010) Microglial Interactions with synapses are modulated by visual experience. PLoS Biol 8(11):e1000527","DOI":"10.1371\/journal.pbio.1000527"},{"issue":"5","key":"3810_CR91","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.ajpath.2012.01.024","volume":"180","author":"Y Xu","year":"2012","unstructured":"Xu Y et al (2012) Altered expression of CX3CL1 in patients with epilepsy and in a rat model. Am J Pathol 180(5):1950\u20131962","journal-title":"Am J Pathol"},{"key":"3810_CR92","doi-asserted-by":"publisher","first-page":"112371","DOI":"10.1016\/j.bbr.2019.112371","volume":"381","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020) Involvement of CX3CL1\/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism. Behav Brain Res 381:112371","journal-title":"Behav Brain Res"},{"key":"3810_CR93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pbb.2014.05.006","volume":"124","author":"G Ping","year":"2014","unstructured":"Ping G et al (2014) Valsartan reverses depressive\/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice. Pharmacol Biochem Behav 124:5\u201312","journal-title":"Pharmacol Biochem Behav"},{"key":"3810_CR94","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11481-006-9017-3","volume":"1","author":"CM Buckner","year":"2006","unstructured":"Buckner CM et al (2006) Neuroimmunity and the blood\u2013brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J Neuroimmune Pharmacol 1:160\u2013181","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"3810_CR95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-018-1220-7","volume":"15","author":"J Verite","year":"2018","unstructured":"Verite J et al (2018) Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice. J Neuroinflammation 15(1):182","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3810_CR96","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","volume":"5","author":"FG Gilliam","year":"2006","unstructured":"Gilliam FG et al (2006) Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurology 5(5):399\u2013405","journal-title":"Lancet Neurology"},{"issue":"5","key":"3810_CR97","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/epi.13651","volume":"58","author":"SJ Gill","year":"2017","unstructured":"Gill SJ et al (2017) Depression screening tools in persons with epilepsy: a systematic review of validated tools. Epilepsia 58(5):695\u2013705","journal-title":"Epilepsia"},{"key":"3810_CR98","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.yebeh.2014.03.003","volume":"34","author":"GN de Oliveira","year":"2014","unstructured":"de Oliveira GN et al (2014) Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI). Epilepsy Behav 34:50\u201354","journal-title":"Epilepsy Behav"},{"key":"3810_CR99","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0920-1211(99)00117-5","volume":"39","author":"Q Ansgar","year":"2000","unstructured":"Ansgar Q et al (2000) Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 39:121\u2013125","journal-title":"Epilepsy Res"},{"key":"3810_CR100","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1176\/appi.ajp.159.7.1112","volume":"159","author":"F Thomas","year":"2002","unstructured":"Thomas F et al (2002) Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159:1112\u20131118","journal-title":"Am J Psychiatry"},{"issue":"4","key":"3810_CR101","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1528-1167.2010.02928.x","volume":"52","author":"A Finegersh","year":"2011","unstructured":"Finegersh A et al (2011) Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures. Epilepsia 52(4):689\u2013697","journal-title":"Epilepsia"},{"key":"3810_CR102","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yebeh.2014.02.034","volume":"34","author":"H Hecimovic","year":"2014","unstructured":"Hecimovic H et al (2014) Severe hippocampal atrophy is not associated with depression in temporal lobe epilepsy. Epilepsy Behav 34:9\u201314","journal-title":"Epilepsy Behav"},{"issue":"5","key":"3810_CR103","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/j.1528-1167.2008.01883.x","volume":"50","author":"S Shamim","year":"2009","unstructured":"Shamim S et al (2009) Temporal lobe epilepsy, depression, and hippocampal volume. Epilepsia 50(5):1067\u20131071","journal-title":"Epilepsia"},{"issue":"11","key":"3810_CR104","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/jnnp.2006.104521","volume":"78","author":"RS Briellmann","year":"2007","unstructured":"Briellmann RS, Hopwood MJ, Jackson GD (2007) Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates. J Neurol Neurosurg Psychiatry 78(11):1226\u20131230","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3810_CR105","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.yebeh.2006.11.013","volume":"10","author":"EJ Richardson","year":"2007","unstructured":"Richardson EJ et al (2007) Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav 10(2):242\u2013249","journal-title":"Epilepsy Behav"},{"key":"3810_CR106","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.seizure.2019.11.015","volume":"74","author":"JS Peedicail","year":"2020","unstructured":"Peedicail JS et al (2020) Long term sequelae of amygdala enlargement in temporal lobe epilepsy. Seizure 74:33\u201340","journal-title":"Seizure"},{"key":"3810_CR107","doi-asserted-by":"publisher","first-page":"107180","DOI":"10.1016\/j.yebeh.2020.107180","volume":"111","author":"V Marcian","year":"2020","unstructured":"Marcian V et al (2020) Cerebrocerebellar structural covariance in temporal lobe epilepsy with hippocampal sclerosis. Epilepsy Behav 111:107180","journal-title":"Epilepsy Behav"},{"issue":"7","key":"3810_CR108","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1212\/WNL.0000000000006905","volume":"92","author":"G Rayner","year":"2019","unstructured":"Rayner G et al (2019) Looking beyond lesions for causes of neuropsychological impairment in epilepsy. Neurology 92(7):e680\u2013e689","journal-title":"Neurology"},{"issue":"2","key":"3810_CR109","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/epi.17140","volume":"63","author":"M Mula","year":"2022","unstructured":"Mula M et al (2022) ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia 63(2):316\u2013334","journal-title":"Epilepsia"},{"issue":"4","key":"3810_CR110","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1037\/0022-006X.75.4.523","volume":"75","author":"DR Strunk","year":"2007","unstructured":"Strunk DR et al (2007) Patients\u2019 competence in and performance of cognitive therapy skills: relation to the reduction of relapse risk following treatment for depression. J Consult Clin Psychol 75(4):523\u2013530","journal-title":"J Consult Clin Psychol"},{"key":"3810_CR111","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jad.2014.02.026","volume":"159","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers P et al (2014) The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord 159:118\u2013126","journal-title":"J Affect Disord"},{"key":"3810_CR112","doi-asserted-by":"publisher","first-page":"106696","DOI":"10.1016\/j.eplepsyres.2021.106696","volume":"175","author":"Z Wei","year":"2021","unstructured":"Wei Z et al (2021) Network of depression and anxiety symptoms in patients with epilepsy. Epilepsy Res 175:106696","journal-title":"Epilepsy Res"},{"issue":"11","key":"3810_CR113","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/j.1528-1167.2011.03276.x","volume":"52","author":"MP Kerr","year":"2011","unstructured":"Kerr MP et al (2011) International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 52(11):2133\u20132138","journal-title":"Epilepsia"},{"issue":"11","key":"3810_CR114","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/jnnp-2018-317997","volume":"89","author":"AJ Noble","year":"2018","unstructured":"Noble AJ et al (2018) Cognitive-behavioural therapy does not meaningfully reduce depression in most people with epilepsy: a systematic review of clinically reliable improvement. J Neurol Neurosurg Psychiatry 89(11):1129\u20131137","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"3810_CR115","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/epi.14444","volume":"59","author":"R Michaelis","year":"2018","unstructured":"Michaelis R et al (2018) Psychological treatments for adults and children with epilepsy: evidence-based recommendations by the International League Against Epilepsy Psychology Task Force. Epilepsia 59(7):1282\u20131302","journal-title":"Epilepsia"},{"issue":"2","key":"3810_CR116","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/ebeh.2000.0050","volume":"1","author":"AM Kanner","year":"2000","unstructured":"Kanner AM, Kozak AM, Frey M (2000) The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 1(2):100\u2013105","journal-title":"Epilepsy Behav"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03810-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03810-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03810-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:17:59Z","timestamp":1720617479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03810-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":116,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3810"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03810-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"assertion":[{"value":"26 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}